Palatin Technologies
PTN
#10951
Rank
S$10.52 M
Marketcap
S$5.91
Share price
-7.10%
Change (1 day)
-80.18%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -S$10.77 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$13.18 Million. In 2025 the company made an earning of -S$12.41 Million, an increase over its 2024 earnings that were of -S$34.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$10.77 Million-13.26%
2025 -S$12.41 Million-64.29%
2024 -S$34.75 Million-16.9%
2023 -S$41.82 Million5.99%
2022 -S$39.46 Million-13.7%
2021 -S$45.72 Million33.25%
2020 -S$34.31 Million-172.11%
2019 S$47.57 M2352.33%
2018 S$1.94 M-94.13%
2017 S$33.06 M-154.92%
2016 -S$60.2 Million3.67%
2015 -S$58.07 Million878%
2014 -S$5.94 Million-72.64%
2013 -S$21.7 Million-33.11%
2012 -S$32.44 Million77.71%
2011 -S$18.26 Million
2003 -S$30.92 Million29.93%
2002 -S$23.8 Million36.18%
2001 -S$17.47 Million
1999 -S$14.5 Million6.04%
1998 -S$13.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$19.46 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.11 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$13.87 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$78.57 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.20 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$38.04 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.28 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA